Nanjing Vazyme Biotech Co., Ltd. (688105.SS)
CNY 23.21
(-1.9%)
CNY 23.21
(-1.9%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 106.89 Million CNY | -16.28% |
| 2022 | 127.67 Million CNY | 113.03% |
| 2021 | 59.93 Million CNY | 74.6% |
| 2020 | 34.32 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 159.1 Million CNY | 0.0% |
| 2024 Q1 | 147.28 Million CNY | 100.0% |
| 2024 Q2 | 172.36 Million CNY | 0.0% |
| 2023 Q2 | 107.7 Million CNY | -14.36% |
| 2023 FY | 106.89 Million CNY | -16.28% |
| 2023 Q4 | 106.89 Million CNY | 37.85% |
| 2023 Q3 | 77.54 Million CNY | -28.0% |
| 2023 Q1 | 125.76 Million CNY | -1.5% |
| 2022 Q2 | 127.67 Million CNY | 51.92% |
| 2022 Q1 | 84.04 Million CNY | 40.23% |
| 2022 FY | 127.67 Million CNY | 113.03% |
| 2022 Q4 | 127.67 Million CNY | -15.28% |
| 2022 Q3 | 150.71 Million CNY | 18.04% |
| 2021 FY | 59.93 Million CNY | 74.6% |
| 2021 Q2 | 63.02 Million CNY | 0.0% |
| 2021 Q4 | 59.93 Million CNY | 6.21% |
| 2021 Q3 | 56.42 Million CNY | -10.47% |
| 2021 Q1 | - CNY | -100.0% |
| 2020 FY | 34.32 Million CNY | 0.0% |
| 2020 Q4 | 1.00 CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |